Back

The impact of midodrine on patients with heart failure with reduced ejection fraction- retrospective cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Managing comorbidities in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jamal Mahar

Banner University Medical Center Phoenix, Phoenix (United States of America)

6 More presentations in this session

Presentation thumbnail
Stimulation in home based cardiac rehabilitation protocol, the effect on aerobic capacity and quality of life
Assistant Professor R. Kallel (Gabes, TN)
Abstract Slides
Presentation thumbnail
Survival impact of amiodarone therapy in heart failure: insights from the Icelandic Heart Failure registry
Doctor P. Gudjonsson (Reykjavik, IS)
Abstract Slides
Presentation thumbnail
Efficacy and safety of GLP-1 agonists in obesity-related heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized placebo-controlled trials.
Miss J. Khater (Beirut, LB)
Abstract Slides
Presentation thumbnail
Efficacy of intravenous and oral iron replacement therapies in heart failure: a network meta-analysis
Mr R. Mizori (London, GB)
Abstract Slides
Presentation thumbnail
Efficacy of liposomal bivalent stabilized iron sulfate in improving iron deficiency and quality of life in patients with chronic heart failure: lower costs for better therapy?
Doctor E. Tagliamonte (Nocera Inferiore, IT)
Abstract Slides

Access the full session

Session thumbnail
Managing comorbidities in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources